Real World Assessment of People Living With Chronic Hepatitis B in Australia

NCT04914611 · tracked via the Priya Life Science Australia tracker

Sponsor

Kirby Institute

Phase

Observational

Started

2022-02-17

Last updated

2026-05-19

Condition(s) studied

Hepatitis B

Investigational drug(s) / intervention(s)

No intervention

No intervention: No intervention

Study summary

The REACH-B study establishes an observational cohort study of people living with chronic hepatitis B from a national network, including a diverse range of services, to characterise and monitor hepatitis B linkage to care and treatment requirements amongst this population.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: 1. All individuals diagnosed with chronic hepatitis B in the participating study sites are eligible to be included (both newly diagnosed cases and those diagnosed in the past). 2. 16 years of age or older. 3. Attended the health service for HBV care within the prior 12 months from study commencement (retrospective recruitment) OR Attending the health service for HBV care from study commencement (prospective recruitment) Exclusion Criteria: 1\. Nil

Primary outcome measure(s)

Characterisation of HBV — July 2027
To characterise and monitor hepatitis B linkage to care and treatment requirements amongst people living with chronic hepatitis B

Trial sites (19)

Facility	City	Region	Status
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)	Sydney	New South Wales	Active Not Recruiting
St Vincent's Hospital	Sydney	New South Wales	Recruiting
Justice Health and Forensic Mental Health Network	Sydney	New South Wales	Recruiting
Blacktown Mount Druitt Hospital	Sydney	New South Wales	Recruiting
Westmead Hospital	Sydney	New South Wales	Recruiting
Menzies School of Health Research (Royal Darwin & Alice Springs Hospitals)	Darwin	Northern Territory	Recruiting
Top End Medical Centre	Darwin	Northern Territory	Recruiting
Sunshine Coast University Hospital	Birtinya	Queensland	Recruiting
Cairns and Hinterland Hospital Health Service	Cairns	Queensland	Recruiting
Torres and Cape Hospital and Health Service	Cairns	Queensland	Recruiting
Central Adelaide Local Health Network (Royal Adelaide & The Queen Elizabeth Hospitals)	Adelaide	South Australia	Recruiting
The Alfred Hospital	Melbourne	Victoria	Not Yet Recruiting
Cohealth	Melbourne	Victoria	Not Yet Recruiting
Utopia Refugee and Asylum Seeker Health	Melbourne	Victoria	Recruiting
Royal Melbourne Hospital	Melbourne	Victoria	Recruiting
St Vincent's Hospital	Melbourne	Victoria	Not Yet Recruiting
Albany Health Campus, WACHS Great Southern	Albany	Western Australia	Recruiting
Broome Regional Hospital, WACHS Kimberley	Broome	Western Australia	Recruiting
Kalgoorlie Health Campus, WACHS Goldfields	Kalgoorlie-Boulder	Western Australia	Recruiting

More Kirby Institute trials in Australia

Swabs in Screening for HPV (SWISH) Starting soon

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Recruiting

The Australian HCV Point-of-Care Testing Program Recruiting

Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir Recruiting

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset Recruiting

Other trials for the same condition

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) Active, not recruiting

Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04914611 on ClinicalTrials.gov ↗ ← All trials in Australia